Glycon M 50/500mg Tablet contains sitagliptin 50mg and metformin hydrochloride 500mg, an oral antidiabetic combination used with diet and exercise to improve blood glucose control in adults with type 2 diabetes.

Sitagliptin is a DPP-4 inhibitor that helps increase incretin activity, supporting insulin release when blood glucose is elevated and reducing glucagon release. Metformin helps reduce glucose production by the liver and improves the body's sensitivity to insulin. Together, they provide complementary blood-sugar-lowering effects.

Uses

• Helps control blood sugar in adults with type 2 diabetes
• Used alongside a healthy diet and regular exercise
• Helps reduce glucose production by the liver
• Supports insulin release when blood glucose is elevated
• May be prescribed when combination therapy is needed for better glycemic control
• Helps improve overall blood glucose management

Benefits

• Combines sitagliptin and metformin in one tablet
• Helps lower elevated blood glucose levels
• Supports better insulin response
• Helps reduce excessive glucose production by the liver
• Has a relatively low risk of hypoglycemia when used appropriately
• Convenient combination therapy

Dosage

• Take Glycon M 50mg/500mg exactly as prescribed by your doctor.
• It is generally taken with meals to reduce stomach-related side effects from metformin.
• Swallow the tablet with water.
• The dose and frequency depend on blood glucose control, kidney function, and previous diabetes treatment.
• Your doctor may monitor kidney function during treatment.
• Do not crush or chew the tablet unless the product instructions specifically permit it.
• Do not change the dose or stop treatment without medical advice.

Possible Side Effects

Some people may experience:

• Nausea
• Diarrhea
• Stomach discomfort
• Abdominal pain
• Headache
• Nasal congestion or sore throat

Rare but serious complications may include lactic acidosis associated with metformin or pancreatitis associated with sitagliptin. Seek urgent medical attention for severe or persistent abdominal pain, repeated vomiting, severe weakness, difficulty breathing, confusion, or unusual sleepiness.

Precautions

• Tell your doctor if you have kidney disease, liver disease, heart failure, or a history of pancreatitis.
• Kidney function should be assessed before and during metformin-containing treatment as recommended.
• Avoid excessive alcohol because it may increase the risk of metformin-associated lactic acidosis.
• Inform your doctor before surgery, prolonged fasting, or certain contrast-dye imaging procedures because treatment may need temporary interruption.
• The risk of hypoglycemia can increase when Glycon M is combined with insulin or sulfonylureas.
• Inform your doctor about all medicines, vitamins, and supplements you take.
• Do not use this medicine as a replacement for insulin in people with type 1 diabetes.

FAQs

Q1: What is Glycon M 50mg/500mg Tablet used for?

Glycon M contains sitagliptin and metformin and is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

Q2: How does Glycon M 50/500mg work?

Sitagliptin helps increase incretin activity, supporting insulin release and reducing glucagon when blood glucose is elevated. Metformin reduces glucose production by the liver and improves insulin sensitivity.

Q3: Should Glycon M be taken with food?

Yes. It is generally taken with meals to improve gastrointestinal tolerance associated with metformin. Follow your doctor's prescribed schedule.

Q4: Can Glycon M cause low blood sugar?

The combination has a relatively low risk of hypoglycemia when used alone, but the risk may increase when it is combined with insulin or sulfonylurea medicines.

Q5: Can people with kidney problems take Glycon M 50/500mg?

Sitagliptin and metformin both require consideration of kidney function. Your doctor should assess kidney function and determine whether this combination and dose are appropriate.

Q6: Can Glycon M 50/500mg be used for type 1 diabetes?

No. Glycon M is intended for type 2 diabetes and does not replace insulin therapy for type 1 diabetes.